Compare Barclays PLC (BCS) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Barclays PLC vs Medpace Holdings Inc — how do they compare? Barclays PLC trades at $28 (market cap $93.87B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Barclays PLC is far larger — about 5.6× Medpace Holdings Inc's market cap, and Barclays PLC pays a 2.19% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| BCS | MEDP | |
|---|---|---|
Market Cap | $93.87B | $16.90B |
Sector | Financials | Technology |
52-Week High | $28.56 | $620.59 |
52-Week Low | $19.36 | $393.42 |
Dividend Yield | 2.19% | — |
Enterprise Value | — | $16.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Barclays PLC
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
